Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregor Zemljič

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Stem Cells International|March 15, 2018
Stem Cell Therapy in Patients with Chronic Nonischemic Heart FailureGregor Poglajen, Gregor Zemljič, Sabina Frljak, et al.
Cell Transplantation|May 4, 2019
Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart FailureGregor Poglajen, Gregor Zemljič, Andraž Cerar, et al.
Current Heart Failure Reports|August 13, 2020
Stem Cell Therapy for Chronic and Advanced Heart FailureGregor Poglajen, Sabina Frljak, Gregor Zemljič, et al.
Diagnostics (Basel, Switzerland)|August 1, 2020
Long-Term Effects of Angiotensin Receptor-Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection FractionGregor Poglajen, Ajda Anžič-Drofenik, Gregor Zemljič, et al.
Biomedicines|November 27, 2025
SGLT2 Inhibitors Are Associated with Left Ventricular Reverse Remodeling in Patients with Non-Compaction Cardiomyopathy-A Prospective Observational Cohort TrialAndraž Cerar, Gregor Poglajen, Gregor Zemljič, et al.
JHLT Open|June 15, 2026
Management of Tacrolimus-induced thrombotic microangiopathy in a heart transplant recipient: Utilizing novel immunosuppression strategiesPetra Girandon Sušanj, Renata Okrajšek, Sabina Frljak, et al.
Journal of Cardiovascular Development and Disease|January 27, 2026
Vericiguat Therapy Is Associated with Reverse Myocardial Remodeling in Chronic Heart Failure with Reduced Ejection FractionTine Bajec, Neža Žorž, Sabina Ugovšek, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Stem Cells International|March 15, 2018
Stem Cell Therapy in Patients with Chronic Nonischemic Heart FailureGregor Poglajen, Gregor Zemljič, Sabina Frljak, et al.
Cell Transplantation|May 4, 2019
Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart FailureGregor Poglajen, Gregor Zemljič, Andraž Cerar, et al.
Current Heart Failure Reports|August 13, 2020
Stem Cell Therapy for Chronic and Advanced Heart FailureGregor Poglajen, Sabina Frljak, Gregor Zemljič, et al.
Diagnostics (Basel, Switzerland)|August 1, 2020
Long-Term Effects of Angiotensin Receptor-Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection FractionGregor Poglajen, Ajda Anžič-Drofenik, Gregor Zemljič, et al.
Biomedicines|November 27, 2025
SGLT2 Inhibitors Are Associated with Left Ventricular Reverse Remodeling in Patients with Non-Compaction Cardiomyopathy-A Prospective Observational Cohort TrialAndraž Cerar, Gregor Poglajen, Gregor Zemljič, et al.
JHLT Open|June 15, 2026
Management of Tacrolimus-induced thrombotic microangiopathy in a heart transplant recipient: Utilizing novel immunosuppression strategiesPetra Girandon Sušanj, Renata Okrajšek, Sabina Frljak, et al.
Journal of Cardiovascular Development and Disease|January 27, 2026
Vericiguat Therapy Is Associated with Reverse Myocardial Remodeling in Chronic Heart Failure with Reduced Ejection FractionTine Bajec, Neža Žorž, Sabina Ugovšek, et al.
Pageof 1